pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Eli Lilly and Co · news · pharmadog
← back to Eli Lilly and Co
News mentioning Eli Lilly and Co
184
stories
Oct 8, 26
Eli Lilly and the LA Dodgers: A tale of 2 dynasties
biospace
Oct 7, 26
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
biospace
Oct 7, 26
5 biggest venture capital raises of Q3 2026
biospace
Oct 5, 26
Lilly doubles down on Gate alliance to unlock new drug class with another $870M+ in biobucks
biospace
Oct 5, 26
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
biopharma dive
Oct 2, 26
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
stat
Oct 1, 26
3 takeaways from a European obesity scientific meeting
biopharma dive
Oct 1, 26
Foghorn lays off 40% of staff after Lilly collaboration ends
biospace
Oct 1, 26
M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy
biospace
Sep 30, 26
Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3
biospace
Sep 30, 26
Lilly builds commercial case for GLP-1 products over Novo with indirect analyses
biospace
Sep 29, 26
Roche cuts muscle-sparing obesity drug after mid-stage disappointment
biospace
Sep 28, 26
6 immunology targets to sustain a mammoth I&I market
biospace
Sep 25, 26
Nektar prevails in legal battle with Lilly over broken rezpeg partnership
biospace
Sep 25, 26
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
biopharma dive
Sep 24, 26
Lilly’s latest China drug deal; Immunovant’s setback in lupus
biopharma dive
Sep 24, 26
STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more
stat
Sep 24, 26
Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry
biospace
Sep 24, 26
Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare
biospace
Sep 23, 26
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
biospace
Sep 23, 26
9 companies hiring in Pennsylvania now
biospace
Sep 23, 26
Pharmas face off for manufacturing talent amidst reshoring efforts
biospace
Sep 22, 26
STAT+: Did the Trump administration just cut Novo a huge financial win?
stat
Sep 22, 26
Viking achieves 'maintenance trifecta' as GLP-1/GIP dual agonist exceeds expectations
biospace
Sep 22, 26
Lilly presents early data supporting GLP-1/GIP candidate's potential in depression, alcohol use disorder
biospace
Sep 22, 26
STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
stat
Sep 22, 26
Roche’s Carmot asset normalizes blood sugar, cuts weight in Phase 2 diabetes trial
biospace
Sep 21, 26
Novo talks up drug launches in effort to win back investors
biopharma dive
Sep 17, 26
Fed rate hike won’t hold biotech down despite climbing capital costs
biospace
Sep 17, 26
Trending: Top biopharma disciplines with jobs live now
biospace
← prev
page 3 of 7
next →